Compare BNZI & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNZI | VRAX |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United Kingdom |
| Employees | 34 | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 1.7M |
| IPO Year | N/A | 2021 |
| Metric | BNZI | VRAX |
|---|---|---|
| Price | $0.56 | $0.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $24.00 | $1.00 |
| AVG Volume (30 Days) | 810.9K | ★ 18.9M |
| Earning Date | 05-14-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.28 | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $0.10 |
| 52 Week High | $4.44 | $1.18 |
| Indicator | BNZI | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 40.51 |
| Support Level | $0.53 | $0.10 |
| Resistance Level | $0.76 | $0.26 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 11.00 | 25.76 |
Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.